Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH.
Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH.
Urology. 2019 Jul;129:98-105. doi: 10.1016/j.urology.2018.11.059. Epub 2019 Jan 29.
To compare perioperative and oncological outcomes of intracorporeal (ICUD) vs extracorporeal urinary diversion (ECUD) after robot-assisted radical cystectomy (RARC).
From January 2014 to December 2017, data of consecutive patients who underwent RARC performed by 2 institutional surgeons were prospectively collected in a dedicated database (IRB: 251647). Patients were divided in 2 groups according to the operating surgeon, one performing ECUD, the other ICUD. Groups were compared in perioperative outcomes and Clavien complications (during admission, within 30- and 90-days postoperatively). Univariable and multivariable analyses tested the impact of variables of interest on the occurrence of complications at the different time points. Kaplan-Meier method was used to estimate recurrence and metastasis-free survivals.
Sixty to 66 patients underwent RARC with ileal conduit ICUD and ECUD, respectively. ICUD patients were younger (69 vs 73 years old, P = .009). No differences were found in other baseline characteristics and final pathology. Regarding perioperative outcomes, shorter operative time favored ECUD (7 vs 6 hours, P = .0004). Specifically, no differences were found in postoperative complications while admitted, either overall (ICUD: 16 [26.7%] vs ECUD: 23 [34.8%] patients, P = .3) or major (ICUD: 10 [16.7%] vs ECUD: 14 [21.2%], P = .6); same was for reassessment within 30- and 90-days postoperatively. At multivariable analysis, Charlson's Comorbidity Index ≥3 and blood losses >600 mL predicted complications during the admission (P = .02). Male gender, higher body mass index, and ureteral involvement predicted 30-days complications (P = .04). No differences in oncological outcomes.
At head-to-head comparison of 2 expert surgeons, ICUD and ECUD for ileal conduit had comparable perioperative outcomes.
比较机器人辅助根治性膀胱切除术(RARC)后腔内(ICUD)与体外(ECUD)尿流改道的围手术期和肿瘤学结果。
从 2014 年 1 月至 2017 年 12 月,通过 2 位机构外科医生进行前瞻性收集连续患者的数据RARC 在专用数据库中(IRB:251647)。根据手术医生将患者分为 2 组,一组进行 ECUD,另一组进行 ICUD。比较两组围手术期结果和 Clavien 并发症(住院期间、术后 30 天和 90 天)。单变量和多变量分析测试了变量对不同时间点并发症发生的影响。Kaplan-Meier 法用于估计复发和无转移生存率。
60 至 66 例患者分别接受了 RARC 伴回肠导管 ICUD 和 ECUD。ICUD 患者年龄较小(69 岁比 73 岁,P=0.009)。其他基线特征和最终病理无差异。关于围手术期结果,ECUD 手术时间更短(7 小时比 6 小时,P=0.0004)。具体来说,住院期间术后并发症无差异(ICUD:16 [26.7%] 例与 ECUD:23 [34.8%] 例,P=0.3)或主要并发症(ICUD:10 [16.7%] 例与 ECUD:14 [21.2%] 例,P=0.6);术后 30 天和 90 天复查也是如此。多变量分析显示,Charlson 合并症指数≥3 和失血量>600 mL 预测住院期间并发症(P=0.02)。男性、较高的体重指数和输尿管受累预测 30 天并发症(P=0.04)。肿瘤学结果无差异。
在 2 位专家外科医生的头对头比较中,ICUD 和 ECUD 用于回肠导管的围手术期结果相当。